The role of human papillomavirus infection in breast cancer

Medical Oncology

Volumn 29, Issue 1, 2012, Pages 48-55

  Wang, Ting ^a   Chang, Peng ^a   Wang, Ling ^a   Yao, Qing ^a   Guo, Wen ^a   Chen, Jianghao ^a   Yan, Tristan ^b   Cao, Christopher ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Breast cancer; Human papillomavirus

Indexed keywords

BREAST CANCER; CANCER TISSUE; DISEASE ASSOCIATION; DOT HYBRIDIZATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENOME; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; INFECTION RISK; MOLECULAR DYNAMICS; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; VIRUS VIRULENCE;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MICE; PAPILLOMAVIRUS INFECTIONS;

EID: 84864069473     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9812-9     Document Type: Review

References (68)

1. Amarante MK, Watanabe MA. The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol. 2009;135:329-37.
2. Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9:S73-81.
3. Joshi D, Quadri M, Gangane N, et al. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One. 2009;4:e8180.
4. Altundag K, Baptista MZ. Human papilloma virus and breast cancer. Br J Cancer. 2006;94:338. author reply 339. (Pubitemid 43151557)
5. Melana SM, Nepomnaschy I, Hasa J, et al. Detection of human mammary tumour virus proteins in human breast cancer cells. J Virol Methods. 2010;163:157-61.
6. Sifuentes Alvarez A, Reyes Romero M. Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care. Ginecol Obstet Mex. 2003;71:12-5. (Pubitemid 36512547)
7. Hausen HZ. Papillomaviruses-to vaccination and beyond. Biochemistry (Mosc). 2008;73:498-503.
8. Gentschev I, Stritzker J, Hofmann E, et al. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther. 2009;16:320-8.
9. Buonaguro FM, Tornesello ML, Buonaguro L. Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Rev Vaccines. 2009;8:1379-98.
10. Munger K, Baldwin A, Edwards KM, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 2004;78:11451-60. (Pubitemid 39390733)
11. Holly EA. Cervical intraepithelial neoplasia, cervical cancer, and HPV. Annu Rev Public Health. 1996;17:69-84. (Pubitemid 26146346)
12. Pizzighella S, Rassu M, Piacentini I, et al. Polymerase chain reaction amplification and restriction enzyme typing as an accurate and simple way to detect and identify human papillomavi-ruses. J Med Microbiol. 1993;39:33-8. (Pubitemid 23231838)
13. Yang L, Mohr I, Fouts E, et al. The E1 protein of bovine papil-loma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci USA. 1993;90:5086-90. (Pubitemid 23182981)
14. Rintala MA, Grenman SE, Puranen MH, et al. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol. 2005;43:376-81. (Pubitemid 40096326)
15. DiMaio D, Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene. 2001;20:7866-73. (Pubitemid 33135313)
16. Howley PM, Munger K, Werness BA, et al. Molecular mechanisms of transformation by the human papillomaviruses. Princess Takamatsu Symp. 1989;20:199-206.
17. Scheffner M, Huibregtse JM, Vierstra RD, et al. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495-505. (Pubitemid 23335075)
18. Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-7. (Pubitemid 19066153)
19. Dyson N, Guida P, Munger K, et al. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol. 1992;66:6893-902.
20. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol. 1999;9:379-86. (Pubitemid 30184507)
21. Centers for Disease Control and Prevention. Human papilloma-virus: HPV information for clinicians. Ala Nurse. 2008;35:17-9.
22. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-50. (Pubitemid 37328947)
23. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101-5. (Pubitemid 36897943)
24. Nemes JA, Deli L, Nemes Z, et al. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:344-52. (Pubitemid 44233357)
25. Crum CP, McLachlin CM, Tate JE, et al. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol. 1997;9:63-9. (Pubitemid 27137230)
26. Klencke BJ, Palefsky JM. Anal cancer: an HIV-associated cancer. Hematol Oncol Clin North Am. 2003;17:859-72. (Pubitemid 36807601)
27. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 1995;64:1-378.
28. Teitelman AM, Stringer M, Averbuch T, et al. Human papillo-mavirus, current vaccines, and cervical cancer prevention. J Obstet Gynecol Neonatal Nurs. 2009;38:69-80.
29. Rylander E, Ruusuvaara L, Almstromer MW, et al. The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol. 1994;83: 735-7. (Pubitemid 24153469)
30. Sawaya GF, Smith-McCune K. HPV vaccination-more answers, more questions. N Engl J Med. 2007;356:1991-3. (Pubitemid 46740311)
31. Revzina NV, Diclemente RJ. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Int J STD AIDS. 2005;16:528-37. (Pubitemid 41192302)
32. Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nat Rev Cancer. 2003;3: 217-26. (Pubitemid 37328873)
33. Winer RL, Lee SK, Hughes JP, et al. Genital human papillo-mavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218-26. (Pubitemid 36152435)
34. Lipskie TL. A summary of cancer screening guidelines. Chronic Dis Can. 1998;19:112-30.
35. Rambout L, Hopkins L, Hutton B, et al. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ. 2007;177:469-79. (Pubitemid 47359770)
36. de León DC, Montiel DP, Nemcova J, et al. Human papilloma-virus (HPV) in breast tumours: prevalence in a group of Mexican patients. BMC Cancer. 2009;9:26.
37. Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat. 1992;21:95-100.
38. Hennig EM, Suo Z, Thoresen S, et al. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intra-epithelial neoplasia (CIN III). Breast Cancer Res Treat. 1999;53: 121-35. (Pubitemid 29161118)
39. Hennig EM, Kvinnsland S, Holm R, et al. Significant difference in p53 and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas. Acta Oncol. 1999;38:931-8.
40. Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer. 2000;7:33-6.
41. Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol. 2001;4:329-34. (Pubitemid 34693880)
42. Damin AP, Karam R, Zettler CG, et al. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat. 2004;84:131-7. (Pubitemid 38393363)
43. Widschwendter A, Brunhuber T, Wiedemair A, et al. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004;31:292-7. (Pubitemid 39371063)
44. de Villiers EM, Sandstrom RE, zur Hausen H, et al. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res. 2005;7:R1-11.
45. Kan CY, Iacopetta BJ, Lawson JS, et al. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer. 2005;93:946-8. (Pubitemid 41487022)
46. Kroupis C, Markou A, Vourlidis N, et al. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem. 2006;39:727-31. (Pubitemid 44036781)
47. Gumus M, Yumuk PF, Salepci T, et al. HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoural tissue samples. J Exp Clin Cancer Res. 2006;25:515-21. (Pubitemid 46166765)
48. Damin AP, Damin DC, Alexandre CO. HPV infection and breast cancer. Breast. 2007;16:222. (Pubitemid 46796860)
49. Yasmeen A, Bismar TA, Kandouz M, et al. E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells. Cell Cycle. 2007;6:2038-42. (Pubitemid 47327892)
50. Kulka J, Kovalszky I, Svastics E, et al. Lymphoepithelioma-like carcinoma of the breast: not Epstein-Barr virus-, but human papilloma virus-positive. Hum Pathol. 2008;39:298-301.
51. Sarkola M, Rintala M, Grenman S, et al. Human papillomavirus DNA detected in breast milk. Pediatr Infect Dis J. 2008;27:557-8.
52. Akil N, Yasmeen A, Kassab A, et al. High-risk human papillo-mavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer. 2008;99:404-7.
53. Heng B, Glenn WK, Ye Y, et al. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009;101:1345-50.
54. Bratthauer GL, Tavassoli FA, O'Leary TJ. Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract. 1992;188:384-6.
55. Wrede D, Luqmani YA, Coombes RC, et al. Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer. 1992;65:891-4.
56. Gopalkrishna V, Singh UR, Sodhani P, et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat. 1996;39:197-202. (Pubitemid 26283203)
57. Lindel K, Forster A, Altermatt HJ, et al. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast. 2007;16:172-7. (Pubitemid 46488811)
58. de Cremoux P, Thioux M, Lebigot I, et al. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2008;109:55-8. (Pubitemid 351538756)
59. Khan NA, Castillo A, Koriyama C, et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer. 2008;99:408-14.
60. Mendizabal-Ruiz AP, Morales JA, Ramirez-Jirano LJ, et al. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat. 2009;114:189-94.
61. Choi YL, Cho EY, Kim JH, et al. Detection of human papillo-mavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol. 2007;28:327-32. (Pubitemid 351567550)
62. Branca M, Ciotti M, Giorgi C, et al. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2007;130:223-31. (Pubitemid 46097249)
63. zur Hausen H. Human papillomavirus & cervical cancer. Indian J Med Res. 2009;130:209.
64. Vonka V. Causality in medicine: the case of tumours and viruses. Philos Trans R Soc Lond B Biol Sci. 2000;355:1831-41. (Pubitemid 32116945)
65. Lawson JS. Do viruses cause breast cancer? Methods Mol Biol. 2009;471:421-38.
66. Liang W, Tian H. Hypothetic association between human papil-lomavirus infection and breast carcinoma. Med Hypotheses. 2008;70:305-7. (Pubitemid 350297616)
67. Anhang R, Goodman A, Goldie SJ. HPV communication.review of existing research and recommendations for patient education. CA Cancer J Clin. 2004;54:248-59. (Pubitemid 39419765)
68. zur Hausen H. The search for infectious causes of human cancers: where and why (Nobel lecture). Angew Chem Int Ed Engl. 2009;48:5798-808.